Adage Capital Partners’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Adage Capital Partners's ANRO Position: Q3 2026 in Review
Adage Capital Partners increased its Alto Neuroscience (ANRO) stake by 6.4% in Q3 2026, buying an estimated $3.06M and bringing the position to 1,701,913 shares worth $43.4M. The position accounts for 0.06% of the portfolio, ranked #292.
Adage Capital Partners first reported a position in ANRO in Q1 2026 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Adage Capital Partners held 1,701,913 shares of Alto Neuroscience worth $43.4M as of Q3 2026.
- Adage Capital Partners bought 101,913 Alto Neuroscience shares in Q3 2026, an estimated $3.06M.
- Alto Neuroscience made up 0.06% of Adage Capital Partners's portfolio in Q3 2026, its #292 holding.
- Adage Capital Partners first reported a position in Alto Neuroscience in Q1 2026 and has held it in 3 quarters since.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.